🇺🇸 FDA
Patent

US 12209256

System for protein inactivation and recombinant phages for targeted bacterial killing, infection, biodetection, and as a means of protein extraction

granted A61KA61K35/76

Quick answer

US patent 12209256 (System for protein inactivation and recombinant phages for targeted bacterial killing, infection, biodetection, and as a means of protein extraction) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K35/76